Literature DB >> 2056447

[Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].

T Maeda1, M Takase, A Ishibashi, T Yamamoto, K Sasaki, T Arika, M Yokoo, K Amemiya.   

Abstract

In screening of new antifungal agents, bis(naphthalenemethyl)amines were found to have more potent antifungal activity than clotrimazole. Studies on their structure-activity relationships indicated that benzylamines had potent antifungal activity. Among them, butenafine hydrochloride (N-p-tert-butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride, KP-363) has proved to show the strongest activity. It exhibits a wide spectrum activity in vitro against particularly dermatophytes (87 strains; minimal inhibitory concentration (MIC) range, 0.0015 to 0.05 microgram/ml), and also against Aspergillus (15 strains; MIC range, 0.025 to 0.78 microgram/ml), Cryptococcus neoformans (4 strains; MICs 0.78 and 1.56 micrograms/ml) and yeasts of genus Candida (67 strains; MIC range, 3.13 to greater than 100 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056447     DOI: 10.1248/yakushi1947.111.2_126

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  9 in total

Review 1.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

2.  In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.

Authors:  Y Tatsumi; M Yokoo; T Arika; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.

Authors:  Yoshiyuki Tatsumi; Mamoru Yokoo; Hisato Senda; Kazuaki Kakehi
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 4.  Butenafine.

Authors:  W McNeely; C M Spencer
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

5.  Experimental and conformational analyses of interactions between butenafine and lipids.

Authors:  M P Mingeot-Leclercq; X Gallet; C Flore; F Van Bambeke; J Peuvot; R Brasseur
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Two mechanisms of butenafine action in Candida albicans.

Authors:  W Iwatani; T Arika; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Anti-Trichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs.

Authors:  T Arika; T Hase; M Yokoo
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

8.  Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.

Authors:  T Arika; M Yokoo; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

9.  Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activities.

Authors:  Ana María Garzón Porras; Bruna Silva Terra; Taniris Cafiero Braga; Thais Furtado Ferreira Magalhães; Cleide Viviane Buzanello Martins; Danielle Letícia da Silva; Ludmila Matos Baltazar; Ludmila Ferreira Gouveia; Gustavo José Cota de Freitas; Daniel Assis Santos; Maria Aparecida Resende-Stoianoff; Beth Burgwyn Fuchs; Eleftherios Mylonakis; Rossimiriam Pereira de Freitas; Ângelo de Fátima
Journal:  J Adv Res       Date:  2018-06-21       Impact factor: 10.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.